Global Life Sciences Solutions USA LLC

Global Life Sciences Solutions USA LLC, a wholly owned subsidiary of Danaher Corporation headquartered in Marlborough, Massachusetts, supplies advanced scientific equipment, chromatography systems, cell processing devices, consumable biological materials, and specialized maintenance services to federal research institutions as a prime contractor on full-and-open federal procurement. The company competes exclusively without small business set-asides, holding a $10 million single-award Blanket Purchase Agreement with the National Institutes of Health's Office of Logistics and Acquisition Operations (effective November 29, 2023 through November 30, 2026) and positions on the GSA Multiple Award Schedule. Global Life Sciences Solutions is classified as a manufacturer of goods under NAICS 334516 (Analytical Laboratory Instrument Manufacturing), with recent award volume spanning life sciences instrumentation, maintenance services, and biological reagents.

The vendor's concrete capability portfolio centers on protein purification and chromatography systems (AKTA PURE, AKTA AVANT, AKTA GO series), surface plasmon resonance instruments (Biacore T200, Biacore 8K systems), controlled-rate freezers (ViaFreeze, ViaThaw), cell processing equipment (SEPAX C-PRO systems), and fluorescence imaging systems (Amersham Typhoon 5). Recent representative contracts include a $40.13 million Other Transaction Agreement with the National Institutes of Health for CRISPR delivery and manufacturing innovation for cancer and HIV therapies (completion September 24, 2031); a $248.857 million purchase order from the Food and Drug Administration for a Cytiva Xcellerex XDuo 100 L jacketed mixer (completion November 24, 2025); a $465.096 million purchase order from FDA for an XDR-50 single-use bioreactor system with training and installation (completion May 18, 2025); and a $1 million definitive contract with NIH Clinical Center for ViaFreeze, ViaThaw, and SEPAX C-PRO cell processing equipment (completion February 2, 2024). The vendor also delivers consumable biological materials including fetal bovine serum, cell culture media, chromatography resins, and nanoparticle formulation cartridges.

Customer concentration is heavily weighted to the National Institutes of Health ecosystem. The top five customer agencies by award count account for 24 percent of recent awards: NIH Office of the Director (236 awards, $1.8 million combined potential value), National Cancer Institute (193 awards, $4.6 million), National Institute of Allergy and Infectious Diseases (193 awards, $5 million), NIAID's Acquisitions subunit (174 awards, $3.1 million), and National Institute of Diabetes and Digestive and Kidney Diseases (133 awards, $2.7 million). When ranked by combined potential value, the top five shift slightly: NIH broadly (103 awards, $40.9 million), FDA (110 awards, $6.5 million), NIAID (193 awards, $5 million), National Cancer Institute (193 awards, $4.6 million), and Department of Army Medical Command (86 awards, $4.1 million). Across the total footprint of 3,862 awards, the vendor serves 124 distinct federal agencies, reflecting deep penetration in NIH institutes and presence across HHS, DoD, VA, EPA, CDC, and other civilian research agencies.

Vehicle position centers on the $10 million NIH BPA (single-award, renewable through November 2026), which generates task orders ranging from $10,000 to $100,000 in individual ceiling values. The Federal Supply Schedule GS26F4791A carries 392 task orders valued at $9.6 million combined; the GSA Multiple Award Schedule accounts for 145 task orders valued at $7.9 million. The vendor also operates under multiple NIH-specific BPAs, including HHSN263200000052400B (112 task orders, $1.1 million) and HHSN263201600055B (101 task orders, $1 million). Task orders under these vehicles reflect modular procurement patterns typical of maintenance and consumables ordering.

Award activity over the past five years shows stability with slight recent decline: 2022 (53 awards), 2023 (47), 2024 (55), 2025 (36), and 2026 year-to-date (7 awards through early September). Combined potential value across all recent awards is $337.9 million, though obligated dollars total $1.43 billion (a 423 percent ratio indicating substantial prior-year obligations). Nineteen awards with completion dates in the next twenty-four months carry combined potential value of $1 million—a modest recompete exposure relative to the vendor's portfolio size.

The vendor holds a subcontractor footprint across federal contractors including Booz Allen Hamilton (providing liquid chromatography system and installation support for Army Ground Vehicle Systems Center), Weems Design Studio, Inc. (NCI and NIAID operational task orders for AKTA and component parts), University of California San Diego (cellular nanosponges medical countermeasure contract with ReadyToProcess bioprocessing equipment), Becton Dickinson (NIAID VRC COVID-19 mRNA vaccine evaluation support), and Roche Diagnostics Corporation (COVID-19 serology testing implementation). Subcontracting is infrequent; the award split shows 3,854 prime awards (100 percent of total) against only 8 sub-awards (less than 1 percent).

Federal grant work includes a cooperative agreement with the Office of the Assistant Secretary for Preparedness and Response (ASPR) for DOD transfer awards (completion June 30, 2035) and a completed cooperative agreement with the Joint PEO Chemical and Biological Defense for COVID-19 response capacity expansion (completion October 24, 2023). The vendor was also recipient of a $72.104 million Other Transaction Agreement with ASPR (completion December 31, 2038) focused on capacity expansion for COVID-19 response and public health emergency support. These grant awards position the company as a critical supplier to HHS preparedness and response infrastructure.

Top NAICS concentrations are Analytical Laboratory Instrument Manufacturing (1,309 awards), Other Electronic and Precision Equipment Repair and Maintenance (607 awards), Research and Development in Biotechnology (78 awards), Electronic and Precision Equipment Repair and Maintenance (51 awards), and In-Vitro Diagnostic Substance Manufacturing (42 awards). Top PSCs are Laboratory Equipment and Supplies (1,183 awards), Maintenance/Repair/Rebuild of Equipment—Instruments and Laboratory Equipment (807 awards), and Medical and Surgical Instruments, Equipment, and Supplies (420 awards). Global Life Sciences Solutions competes full-and-open across all major federal markets with no set-aside category footprint.